You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動丨藥明康德(2359.HK)高開逾3% 去年大賺50.97億元 同比增超72%
格隆匯2月16日丨藥明康德(2359.HK)高開逾3%,報105港元,總市值3104億港元。藥明康德昨晚發佈業績快報,2021年營業收入為229.02億元,同比增長38.5%;歸母淨利潤50.97億元,同比增長72.19%。在這其中,化學業務2021年實現收入約幣140.87億元,同比增長約46.93%。值得關注的是,公司預計化學業務板塊2022年收入增速相較2021的收入增速將近翻番。昨日,藥明系股票均開啟暴漲模式:藥明康德A股收盤漲停,藥明康德港股漲幅達到12.13%,港股藥明生物漲幅10.09%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account